Simon T. Peake

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Recommendations for the optimal use of mesalazine in the management of patients with mild to moderate ulcerative colitis.

Recommendations for the optimal use of mesalazine in the management of patients with mild to moderate ulcerative colitis.

Journal: British journal of hospital medicine (London, England : 2005)

Published: November 02, 2021

Comparative effectiveness of a second-line biologic in patients with ulcerative colitis: vedolizumab followed by an anti-TNF versus anti-TNF followed by vedolizumab.

Comparative effectiveness of a second-line biologic in patients with ulcerative colitis: vedolizumab followed by an anti-TNF versus anti-TNF followed by vedolizumab.

Journal: Frontline gastroenterology

Published: May 10, 2021

Vedolizumab use and the associations between α4β7 expression and HIV reservoir in the gut during treated primary HIV infection.

Vedolizumab use and the associations between α4β7 expression and HIV reservoir in the gut during treated primary HIV infection.

Journal: AIDS (London, England)

Published: November 06, 2019

CD32 expressing doublets in HIV-infected gut-associated lymphoid tissue are associated with a T follicular helper cell phenotype.

CD32 expressing doublets in HIV-infected gut-associated lymphoid tissue are associated with a T follicular helper cell phenotype.

Journal: Mucosal immunology

Published: June 19, 2018

Chemokine (C-C Motif) Receptor 2 Mediates Dendritic Cell Recruitment to the Human Colon but Is Not Responsible for Differences Observed in Dendritic Cell Subsets, Phenotype, and Function Between the Proximal and Distal Colon.

Chemokine (C-C Motif) Receptor 2 Mediates Dendritic Cell Recruitment to the Human Colon but Is Not Responsible for Differences Observed in Dendritic Cell Subsets, Phenotype, and Function Between the Proximal and Distal Colon.

Journal: Cellular and molecular gastroenterology and hepatology

Published: January 29, 2015

Human gut dendritic cells drive aberrant gut-specific t-cell responses in ulcerative colitis, characterized by increased IL-4 production and loss of IL-22 and IFNγ.

Human gut dendritic cells drive aberrant gut-specific t-cell responses in ulcerative colitis, characterized by increased IL-4 production and loss of IL-22 and IFNγ.

Journal: Inflammatory bowel diseases

Published: November 15, 2014

Compartment-specific immunity in the human gut: properties and functions of dendritic cells in the colon versus the ileum.

Compartment-specific immunity in the human gut: properties and functions of dendritic cells in the colon versus the ileum.

Journal: Gut

Published: June 25, 2014

Altered human gut dendritic cell properties in ulcerative colitis are reversed by Lactobacillus plantarum extracellular encrypted peptide STp.

Altered human gut dendritic cell properties in ulcerative colitis are reversed by Lactobacillus plantarum extracellular encrypted peptide STp.

Journal: Molecular nutrition & food research

Published: August 14, 2013

Does diverticular disease protect against sigmoid colon cancer?

Does diverticular disease protect against sigmoid colon cancer?

Journal: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland

Published: July 08, 2013

Mechanisms of action of anti-tumor necrosis factor α agents in Crohn's disease.

Mechanisms of action of anti-tumor necrosis factor α agents in Crohn's disease.

Journal: Inflammatory bowel diseases

Published: April 19, 2013

Lost therapeutic potential of monocyte-derived dendritic cells through lost tissue homing: stable restoration of gut specificity with retinoic acid.

Lost therapeutic potential of monocyte-derived dendritic cells through lost tissue homing: stable restoration of gut specificity with retinoic acid.

Journal: Clinical and experimental immunology

Published: April 05, 2013

Skin- and gut-homing molecules on human circulating γδ T cells and their dysregulation in inflammatory bowel disease.

Skin- and gut-homing molecules on human circulating γδ T cells and their dysregulation in inflammatory bowel disease.

Journal: Clinical and experimental immunology

Published: October 09, 2012

Showing 1-12 of 16

Last Updated: 09/26/2026